Literature DB >> 26576571

Characterization of the biliary tract by virtual ultrasonography constructed by gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.

Yohei Koizumi1, Masashi Hirooka1, Hironori Ochi1, Yoshio Tokumoto1, Megumi Takechi2, Atsushi Hiraoka3, Yoshio Ikeda1, Teru Kumagi1, Bunzo Matsuura1, Masanori Abe1, Yoichi Hiasa4.   

Abstract

PURPOSE: This study aimed at prospectively evaluating bile duct anatomy on ultrasonography and evaluating the safety and utility of radiofrequency ablation (RFA) assisted by virtual ultrasonography from gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).
METHODS: The institutional review board approved this study, and patients provided written informed consent prior to entry into the study. Bile duct anatomy was assessed in 201 patients who underwent Gd-EOB-DTPA-enhanced MRI for the evaluation of hepatic tumor. Eighty-one of these patients subsequently underwent RFA assisted by ultrasound imaging. In 23 patients, the tumor was located within 5 mm of the central bile duct, as demonstrated by MRI.
RESULTS: Virtual ultrasonography constructed by Gd-EOB-enhanced MRI was able to visualize the common bile duct, left hepatic duct, and right hepatic duct in 96.5, 94.0, and 89.6 % of cases, respectively. The target hepatic tumor nodule and biliary duct could be detected with virtual ultrasonography in all patients, and no severe complications occurred.
CONCLUSION: The running pattern of the bile ducts could be recognized on conventional ultrasound by referencing virtual ultrasonography constructed by Gd-EOB-DTPA-enhanced MRI. RFA assisted by this imaging strategy did not result in bile duct injury.

Entities:  

Keywords:  Bile duct; Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid; Hepatocellular carcinoma; Radiofrequency ablation; Virtual ultrasonography

Mesh:

Substances:

Year:  2014        PMID: 26576571     DOI: 10.1007/s10396-014-0598-9

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  27 in total

Review 1.  Radiofrequency ablation of the liver: current status.

Authors:  J P McGhana; G D Dodd
Journal:  AJR Am J Roentgenol       Date:  2001-01       Impact factor: 3.959

2.  Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.

Authors:  Ryosuke Tateishi; Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Yukihiro Koike; Tomonori Fujishima; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Cancer       Date:  2005-03-15       Impact factor: 6.860

3.  Types and frequencies of biliary tract variations associated with a major portal venous anomaly: analysis with multi-detector row CT cholangiography.

Authors:  Masahiro Kitami; Kei Takase; Gen Murakami; Saiho Ko; Masahiro Tsuboi; Haruo Saito; Shuichi Higano; Yoshiyuki Nakajima; Shoki Takahashi
Journal:  Radiology       Date:  2006-01       Impact factor: 11.105

Review 4.  Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough.

Authors:  G D Dodd; M C Soulen; R A Kane; T Livraghi; W R Lees; Y Yamashita; A R Gillams; O I Karahan; H Rhim
Journal:  Radiographics       Date:  2000 Jan-Feb       Impact factor: 5.333

Review 5.  Complications of radiofrequency coagulation of liver tumours.

Authors:  S Mulier; P Mulier; Y Ni; Y Miao; B Dupas; G Marchal; I De Wever; L Michel
Journal:  Br J Surg       Date:  2002-10       Impact factor: 6.939

6.  Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.

Authors:  T F Wood; D M Rose; M Chung; D P Allegra; L J Foshag; A J Bilchik
Journal:  Ann Surg Oncol       Date:  2000-09       Impact factor: 5.344

7.  Anatomic variations of arterial liver vascularization: an analysis by using MDCTA.

Authors:  Luca Saba; Giorgio Mallarini
Journal:  Surg Radiol Anat       Date:  2011-01-20       Impact factor: 1.246

8.  Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation.

Authors:  Yasunori Minami; Hobyung Chung; Masatoshi Kudo; Satoshi Kitai; Shunsuke Takahashi; Tatsuo Inoue; Kuzuomi Ueshima; Hitoshi Shiozaki
Journal:  AJR Am J Roentgenol       Date:  2008-06       Impact factor: 3.959

9.  Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.

Authors:  Tito Livraghi; Luigi Solbiati; M Franca Meloni; G Scott Gazelle; Elkan F Halpern; S Nahum Goldberg
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

10.  Intraductal chilled saline perfusion to prevent bile duct injury during percutaneous radiofrequency ablation for hepatocellular carcinoma.

Authors:  Takaya Ohnishi; Ichiro Yasuda; Youichi Nishigaki; Hideki Hayashi; Kentaro Otsuji; Tsuyoshi Mukai; Masamichi Enya; Salem Omar; Nib Soehendra; Eiichi Tomita; Hisataka Moriwaki
Journal:  J Gastroenterol Hepatol       Date:  2007-08-07       Impact factor: 4.029

View more
  1 in total

1.  A case of hepatocellular carcinoma treated by radiofrequency ablation confirming the adjacent major bile duct under hybrid contrast mode through a biliary drainage catheter.

Authors:  Yusuke Imai; Masashi Hirooka; Hironori Ochi; Yohei Koizumi; Yoshinori Ohno; Takao Watanabe; Yoshio Tokumoto; Teru Kumagi; Masanori Abe; Yoichi Hiasa
Journal:  Clin J Gastroenterol       Date:  2015-08-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.